Cargando…
Corrigendum: Deferoxamine alleviates osteoarthritis by inhibiting chondrocyte ferroptosis and activating the Nrf2 pathway
Autores principales: | Guo, Zhou, Lin, Jiamin, Sun, Kai, Guo, Jiayou, Yao, Xudong, Wang, Genchun, Hou, Liangcai, Xu, Jingting, Guo, Jiachao, Guo, Fengjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213775/ https://www.ncbi.nlm.nih.gov/pubmed/37251327 http://dx.doi.org/10.3389/fphar.2023.1199951 |
Ejemplares similares
-
Deferoxamine Alleviates Osteoarthritis by Inhibiting Chondrocyte Ferroptosis and Activating the Nrf2 Pathway
por: Guo, Zhou, et al.
Publicado: (2022) -
Chondrocyte ferroptosis contribute to the progression of osteoarthritis
por: Yao, Xudong, et al.
Publicado: (2020) -
Mitoquinone alleviates osteoarthritis progress by activating the NRF2-Parkin axis
por: Hou, Liangcai, et al.
Publicado: (2023) -
Lipid peroxidation in osteoarthritis: focusing on 4-hydroxynonenal, malondialdehyde, and ferroptosis
por: Zhang, Xiong, et al.
Publicado: (2023) -
Astaxanthin protects against osteoarthritis via Nrf2: a guardian of cartilage homeostasis
por: Sun, Kai, et al.
Publicado: (2019)